ART Fertility Clinics
Araz Raberi has over 8 years of experience in the field of genetics and reproductive medicine. They are currently working as the Group Genomics Director at ART Fertility Clinics, starting in December 2021. Prior to this, they held the position of Lead molecular geneticist and Head of PGT-M team at JUNO Genetics from August 2019 to January 2022. They also served as the Deputy Director, Senior Molecular Geneticist, and Quality Manager at IGENOMIX UK (UKAS Accredited) from October 2017 to August 2019. Before that, they worked as a Senior Molecular Geneticist and PGD specialist at Reprogenetics UK (UKAS Accredited) from August 2016 to October 2017. Araz Raberi began their career as a PGD specialist at Reprogenetics UK (CPA Accredited) in August 2013 and stayed until July 2016.
Araz Raberi's education history includes a DPhil in Obstetrics and Gynecology from the University of Oxford, which was obtained between 2013 and 2016. They also earned a Master's degree by Research in Reproductive Biology from The University of Edinburgh in 2011 and 2012. In addition to their academic qualifications, Araz Raberi has obtained several certifications, including membership in The Association for Clinical Genomic Science (ACGS) from The British Society for Genetic Medicine in 2024, a Clinical Scientist_Molecular Genetics certification from the Department of Health Abu Dhabi in 2021, a Combined Laboratory Management certification from UKAS in 2019, and a Pathology Quality & Audit Workshop certification from the Institute of Biomedical Science in 2017.
This person is not in any teams
ART Fertility Clinics
ART Fertility Clinics is a leading institution of Reproductive Medicine with clinics in UAE & India. The institution is known for delivering the highest success rate in the region and has helped thousands of couples achieve their dream of parenthood. Clinical Excellence in Delivering Highest Pregnancy Success Rates , The Most Advanced Technology & Infrastructure and Proprietary research and techniques have established Art Fertility Clinics as Leaders in Fertility Treatments & Research Globally. ART Fertility is renowned world over for its research and latest advancements in Assisted Reproductive Technologies (ART). With international expertise and region-specific know-how, ART Fertility brings exceptional standards of processes, protocols, and policies that have helped thousands of births to date. ART Fertility Clinics was started as an extension of IVI RMA Global in 2015 under the brand name IVI Middle East. In Jan 2020, IVI RMA divested its ownership to Gulf Capital and the entity was rechristened as ART Fertility Clinics. Since its inception, ART Fertility Clinics has been led by Mr. Suresh Soni, Chief Executive Officer, and Prof. Dr. Human Fatemi, Group Medical Director. In the past six years, ART Fertility Clinics has established Clinics in Abu Dhabi, Muscat, and Dubai and become the leading institute for Human Reproductive Medicine in the Middle East. As part of the global expansion initiative mandated by Gulf Capital, ART Fertility has expanded its presence in India, commencing operations in six clinics across India in 2021 with an additional 12 clinics to begin operations by end 2022. ART Fertility Clinics will be announcing the launch of several clinics in Europe and Asia during the second half of 2022.